Bayer | BAYN - Ebit


Bayer reported EUR755M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Air Liquide EUR 2.89B 48.7M Jun/2026
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 44M 253M Jun/2026
Amarin USD -2.26M 564K Dec/2025
Arkema EUR 187.7M 106.8M Jun/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
BASF EUR 188M 1.25B Sep/2026
Bayer EUR 755M 2.77B Jun/2026
Beiersdorf EUR 760M 256M Jun/2026
Corteva USD 1.95B 795.92M Jun/2026
Covestro EUR -324M 5.72B Dec/2025
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 480.55M 212.55M Jun/2026
Genmab DKK 407M 221M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 428M 179M Jun/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Johnson Matthey GBP 198M 56M Jun/2026
Linde USD 2.2B 294M Sep/2026
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Novartis USD 5.14B 411M Sep/2026
Nutrien USD 1.85B 1.48B Jun/2026
Philips EUR 641M 339M Jun/2026
PPG Industries USD 648M 8M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 3.6B Sep/2026
SAP EUR 926M 1.72B Sep/2026
Solvay EUR 71M 7M Jun/2026
UCB EUR 1.29B 571M Dec/2025
Umicore EUR -13.2B 13.91B Jun/2026
Vinci EUR 4.01B 2.04B Jun/2026